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We have recently demonstrated that genes in the VH linkage group control the fine 
specificity of the delayed-type hypersensitivity (DTH) response to nitrophenyl acetyl 
(NP)  (1).  It was shown  that  transfer of reactivity to NP was both T-cell dependent 
and required I-A homology between the donor and recipient animals (1). The studies 
described below were undertaken to further clarify the specificity of the responding T 
cell,  as well  as  the  specificity of other  cells  which  could  be  involved  in  the  DTH 
pathway. 
In  our earlier  studies,  cyclophosphamide-pretreated  mice were  primed  with  NP- 
bovine gamma globulin  (NP-BGG), and NP-specific DTH responses were elicited by 
challenge  with  NP on a  heterologous carrier,  NP-bovine serum albumin  (NP-BSA) 
(1).  Because  of considerable  accumulated  evidence  from  this  laboratory  of carrier 
effects in  DTH reactivity (2-3), 1 the role of the carrier in  the various phases of the 
NP-specific DTH response was explored. To analyze the carrier requirements in this 
response more definitively, we chose to use carriers, the immune response to which are 
under  H-linked Ir gene control. The use of such carriers was motivated by the fact 
that for an Ir-restricted antigen, such as poly-(L-gluS6-L-lys~-L-phe  9)  (GL~), strains of 
mice of the appropriate H-2 haplotype do not manifest detectable immune responses 
or carrier specific helper function (4, 5). Thus, by examining the effect of this antigen 
on the various phases of the hapten-specific DTH response in responder and nonre- 
sponder strains of mice, we were able to gain insight into the role of the carrier moiety 
in the induction and elicitation of NP-specifie DTH responses. 
Materials and Methods 
Animals.  All mice were purchased from The Jackson Laboratory, Bar Harbor, Maine, or 
were bred in the animal facilities of Harvard Medical School. Mice were used at  2-12 mo of 
age, and were maintained on laboratory chow and acidified, chlorinated water ad libitum. 
Antigens.  The linear terpolymer GL~, lot GLP2, average mol wt 45,000, was prepared by 
Miles-Yeda,  Ltd., Rehovot, Israel. The random linear copolymer, poly-(L-glu6°-L-lys4°),  GL, lot 
33, was purchased from Pilot Chemicals, Boston,  Mass.  BSA and BGG were purchased from 
Sigma Chemical  Co.,  St.  Louis,  Mo.  The preparation  of NP-conjugated  proteins has been 
previously described (1). The molar conjugation ratio of haptenic group used in this work were 
NP17-BGG, NPll-BSA, NP14-GLO, and NP16-GL. 
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Immunization and Challenge.  All  animals  described  below,  were  pretreated  with  20  mg/kg 
cyclophosphamide in 0.2  ml  phosphate-buffered saline  (PBS),  injected  intraperitoneally,  3  d 
before  immunization.  The  antigens  were  emulsified,  in  complete  Freund's  adjuvant  (CFA) 
(Difco Laboratories, Detroit,  Mich.)  containing 0.5  mg/ml  Mycobacterium butyricum, so that  the 
antigen  concentration  was  500  #g/ml  of CFA  emulsion.  A  total  of 0.2  ml  of emulsion  was 
injected  subcutaneously bilaterally divided  between two sites on the dorsal flanks. 
7  d  after  immunization,  the  mice  were  challenged.  The  DTH  response  was  elicited  by 
injecting, into the left footpad, 25 p,l of a  solution containing  1 mg/ml of the challenge antigen 
in  PBS.  The amount of footpad swelling was measured, using an engineer's micrometer, 24  h 
after challenge.  Swelling was determined as the difference, in units of 10 -4 in, between the left 
footpad  thickness  and  the  right  footpad  thickness.  All  animals were  measured  by  two  inde- 
pendent observers, whose measurements were then averaged. 
Statistical Analysis.  Analysis of average  differences  of footpad  swelling obtained  was  per- 
formed  with  the  Wang  Programmable  calculator.  The  arithmetic  means  and  SEM  were 
expressed, as well as the relevant  P  value, obtained with the two-tailed Student's t  test.  In this 
paper, any result referred to as significant, had a P value of <<0.01, the P value of nonsignificance 
was P  >  0.05,  unless otherwise indicated. 
Results 
Carrier Requirements  for the Induction of NP-specific DTH.  Mice of various strains were 
injected with 20 mg/kg cyclophosphamide. 3 d  later, the mice were primed with  100 
#g NP-BGG, NP-GLO, or NP-GL in CFA, subcutaneously.  Animals in the negative 
control groups received PBS in CFA.  7 d  after priming, all animals were challenged 
with  25/tl  of a  1 mg/ml PBS solution of NP-BSA. 24 h  after challenge, the amount 
of  footpad  swelling  was  determined  as  the  difference  between  the  injected  and 
uninjected footpad. The amount of footpad swelling was an indication of NP-specific 
priming by the various compounds. 
As  seen  in  Table  I, all  mouse strains  examined  mount  a  significant  NP-specific 
response when primed with NP-BGG compared to the background responses observed 
in control mice which were primed with CFA alone. The ability of NP-GL to prime 
for an NP-specific response was then examined. GL is unable to induce an antibody 
response in all strains of mice thus far examined (5, 6). Similarly, NP-GL was unable 
to prime for an NP-specific response in the four strains examined. This suggested that 
a nonimmunogenic carrier could not be used for priming the DTH response. 
The situation  for a  carrier which  is  immunogenic  in  only some strains was then 
TAaLr  I 
Carrier-mediated Genetic Control of Induction of NP-spec~c  DTH by NP-GI_@ and NP-GL* 
Strain 
H-2 formulae  GI~ re-  NP DTH response 
sponse 
(KABJECSGD)  status  NP-BGG primed  NP-GL  primed  NP-GL~ primed  CFA primed 
BALB/c  ddddddddd  +  43.8 +  1.8~  13.2 +  2.0  NT  11.5 + 3.1 
B10.D2  ddddddddd  +  49.2 + 3.5~  NT  52.4 + 4.3:~  17.4 +  1.8 
B10.S(9R)  ss?kkdddd  +  42.8 :t: 6.1~:  NT  43.8 :t: 2.3:~  9.4 4- 2.2 
BI0.PL  uuuuuuuuu  +  36.6 + 2.7~  12.3+  3.4  53.1 + 5.7:~  11.8±3.9 
C57BL/6  bbbbbbbbb  -  47.2 :t: 3.7~  18.6:1:17.4  15.7 +  1.8  17.2 ± 6.7 
BI0.GD  ddd?bbbbb  -  34.4±  1.9~  11.3±  4.4  15.5±5.0  6.7:t:2.1 
BI0.S  s s ss s s s ss  -  44.1 ± 4.9:[:  NT  2.4 --. 1.5  3.0 :t: 2.8 
NT, not tested. 
* Groups of mice were cyclophosphamide pretreated with 20 mg/kg cyclophosphamide. 3 d later, groups of five mice each 
were primed with 100/,~g of the indicated antigens in 0.2 ml of CFA. 7 d after priming, mice were challenged with 25 
p,l ofa l mg/ml solution of NP-BSA in PBS. Footpad swelling  was measured 24 h after challenge, in units of l0 -* in, The 
arithmetic means +  SE are presented. 
:~ P < 0.01 as compared with CFA-primed negative control J.  z.  WEINBERGER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE II 
Requirements  for Elicitation of NP-specific DTH* 
1257 
Strain  Priming antigen 
DTH challenge 
NP-BSA  NP-GL~  NP-GL 
C57BL/6  NP-BGG  41.6  +  4.6:~  43.4  +  7.1:~  68.4  +  7.1~ 
CFA  17.4 4-  2.3  10.0  +  3.5  8.1  +  3.1 
BALB/c  NP-BGG  43.8  4-  1.8:~  35.2  ±  2,2:~  42,6  -l-  1.6:~ 
CFA  11.5 4- 3,1  10.2  ±  4.1  9.3  ±  2,2 
BI0.PL  NP-BGG  40.9  ±  3.2:~  43.3  ±  6.2:~  50.1  ±  4.9:~ 
CFA  6.3  4-  2.0  7.9 4-  2.8  7.9 4-  3.98 
BI0.GD  NP-BGG  34.4  ±  1,9:~  38.1  ±  1.3:~  49.2  4-  13.8:~ 
CFA  3,1  :t:  1.5  7.9 4-  4.3  4.7  zl:  2.3 
BI0.S  NP-BGG  47,2  ±  8.3~:  44.3  ±  5.2:~  33.5  ±  0.7:~ 
CFA  5.9 4-  1,1  10,2 ±  3,0  5,5  "4- 0.9 
* Cyclophosphamide pretreated mice were primed with  100 pg of NP-BGG in CFA, or with CFA alone. 7 d  later, groups 
of five mice each were challenged with 25 p.g of the indicated compound in 25 #1 of PBS.  24 h  later, the net footpad 
swelling was measured in units of 10  -4 in. The arithmetic means ±  SE are presented. 
:]: P<  0.01 as compared with CFA primed responses. 
examined. GL~ is a random linear terpolymer, the response to which is under Ir gene 
control.  When  various  strains  of mice  were  primed  with  NP-GL~,  not  all  of the 
strains  demonstrated  an  ability  to prime for NP-specific DTH  responses  (Table I). 
Furthermore, the data shows a complete correlation between the ability of NP-GL~ 
to  prime  for  NP-specific  DTH  responses  and  the  cellular  and  humoral  responder 
status to GL~  in the mouse strains examined. This data therefore indicates that the 
ability to prime for NP-specific DTH responses is correlated with a requirement to be 
able to respond to the carrier. 
Carrier Requirements for the Elicitation  of NP-specific  DTH.  The  question  that  next 
arose was, could a  similar Ir gene effect be demonstrated when the NP response was 
elicited  by  the  various  NP  conjugates.  To  this  end,  various  strains  of mice  were 
cyclophosphamide pretreated and  primed with  100 p.g of NP-BGG in CFA or with 
PBS in CFA. 7 d  later, the mice were challenged with NP-BSA, NP-GL~), or NP-GL. 
As  seen  in  Table  II,  NP-BSA  was  able  to  elicit  a  significant  NP-specific  DTH 
response  in  all  strains of mice primed with  NP-BGG. When  NP-GL~ was used  to 
elicit the response, the data clearly shows that this conjugate could also elicit an NP- 
specific response of comparable magnitude. This could be achieved even in strains of 
mice which could not be primed using the same batch of NP-GL~, e.g., B10.GD and 
B 10.S mice (Table I). 
To further document this dichotomy in the capacity of a compound to induce and 
elicit  DTH  responses, we examined  the ability of the nonimmunogenic compound, 
NP-GL, to elicit NP-specific DTH responses. As mentioned previously, mouse strains 
which respond to GL have not been identified (5, 6). The data in Table II demonstrate 
that the NP-specific response may be easily and efficiently elicited by NP-GL in NP- 
BGG  primed  mice.  Furthermore,  NP-BGG  primed  mice  of either  the  B10.GD  or 
B10.PL strains failed to respond when challenged with GL~ (data not shown). Thus, 
the response elicited by NP-GL is not a  result of the recognition of GL determinants. 
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DTH  required  an  H-2-1inked  gene  homology even  when  NP-GL  was  used  in  the 
elicitation  phase  (data  not  shown).  Thus,  the  elicitation  of the  NP-specific  DTH 
response does not  require  use of an immunogenic carrier,  but  is nevertheless MHC 
restricted. 
Discussion 
These experiments were directed at a comparison between the carrier requirements 
for priming and elicitation of NP-specific, T-cell mediated DTH responses.  Priming 
for NP-specific DTH responses was observed to require a genetic ability to respond to 
the carrier to which the NP hapten was conjugated. On the other hand, elicitation of 
an  NP-specific response by appropriately primed mice could even be accomplished 
with  NP-conjugates  of nonimmunogenic  carriers.  Benacerraf and  his colleagues  (3) 
studied  the antigenicity  in guinea pigs of azobenzenearsonate  (ABA) coupled to the 
immunogenic  L  or  nonimmunogenic  D  stereoisomers  of  poly-(glu,ala,tyr)  (GAT). 
Similar to  the  finding  reported  herein,  they observed that  ABA-D-GAT would  not 
sensitize;  however, ABA-D-GAT could nevertheless elicit weak ABA-DTH responses 
in  ABA-L-GAT primed animals.  Kipps et al. 1 also noted  that GA determinants  in 
GLA were unable to prime for a GA-specific DTH response in intermediate responder 
strain mice; nevertheless, GLA could elicit a DTH response in GA-primed mice. 
Several possible mechanisms must be considered to explain the differences in  the 
recipient for priming and elicitation of DTH reactivity. All interpretations must also 
account  for the MHC  restrictions which  exist  in  this system. Thus,  the various NP 
conjugates are presented on the surface of an antigen-presenting-cell in the context of 
an Ia molecule, as evidenced by the I-A homology requirement  on transfer of DTH 
reactivity in such systems (1,  7).  It is possible that  the triggering threshold  of the T 
cell for priming may have a higher thermodynamic energy requirement in the receptor 
interaction  with the antigen-Ia complex, than  the clonally expanded T  cell demon- 
strates  in  the  elicitation  phase.  Priming involves a  complex series of differentiative 
and proliferative steps which could change the magnitude of the signal necessary to 
turn  on  the  T  cells  at  each  step.  A  related  explanation  would  postulate  that  the 
number of precursors recognizing a  low affinity antigen-Ia complexes is so low that 
they would not expand to an extent sufficient to allow detectable priming. However, 
once  the  clones  of NP-reactive  T  cells  are  expanded,  a  sufficient  number  of NP- 
specific cells could be triggered to give a detectable DTH response. 
Another possible mechanism involves the introduction of the notion of maturation 
of affinity of the T-cell receptor in a  manner analogous to that seen in the humoral 
antibody response. At the priming stage, one might envisage a  T  cell with a  rather 
low affinity for a loose antigen-Ia complex. During the period of time between priming 
and elicitation,  the T-cell receptor may mature to develop a  higher affinity for the 
antigen-Ia complex. After receptor maturation,  an NP-specific effector T  cell might 
be able to cross-reactively recognize NP on a nonimmunogenic molecule. 
A  third  more  challenging  possibility  would  implicate  T  cell-T  cell  interaction 
whereby priming of the effector NP-specifie T-cell population is facilitated by a signal 
from a  helper population of T  cells recognizing a covalently linked carrier molecule. 
A  helper  effect  on  DTH  was  previously noted  by  Bullock  et  al.  (8).  Guinea  pigs 
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significantly stronger  protein-specific  DTH  responses  than  those  animals  not  previ- 
ously immunized with ABA-T. 
Finally,  a  less  likely  possibility  is  that  the  antigen-presenting  cells  involved  in 
priming belong to a  different  functional subset  from those involved in elieitation  of 
DTH.  The  former would  present  the  antigen  immunogenically  only  if the  carrier 
could be efficiently linked to an Ia molecule. The latter subset could present  antigen 
to already matured T  cells even in the absence of an immunogenic carrier moiety. At 
this point, there seems to be no compelling evidence for such a  possibility. 
In summary, we have presented several alternative  mechanisms for explaining the 
observed dichotomy between the requirement  for carrier recognition for priming, and 
lack of such a  requirement  for the elicitation of NP-specific DTH  responses. 
Summary 
The genetic requirements  of carrier recognition were examined in the priming and 
elicitation  of hapten  specific, T-cell  mediated,  delayed-type hypersensitivity  (DTH) 
responses.  It  was  shown  that  nitrophenyl  acetyl-poly-(L-gluSn-h-lys35-L-phe  9)  (NP- 
GLO)  could  prime  for  NP  responses  only  in  strains  of mice  which  are  Ir  gene 
responders  to  GLO.  In contrast  to  this  requirement,  NP-GLO could  elicit  an  NP- 
specific  response  in  NP-bovine  gamma globulin  primed  mice,  even  in GLO  nonre- 
sponder strains.  Furthermore, the nonimmunogenic molecule, NP-GL, could elicit an 
NP-specific DTH  response in animals  primed  with  NP on an  immunogenic carrier. 
Received for publication  8 August  1979. 
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